| Name | S07-2001 |
|---|
| Description | S07-2001 is a potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitor with an IC50 value of 2.08 μM. S07-2001 enhances the activity of Doxorubicin against cancer cells. S07-2001 has potential as a chemotherapeutic potentiator for cancer drug resistance[1]. |
|---|---|
| Related Catalog | |
| Target |
S07-2001 (50 μM) reduces 27% of MCF-7 cell viability administrated with Doxorubicin[1]. |
| References |
| Molecular Formula | C15H17N3O4S |
|---|---|
| Molecular Weight | 335.38 |